Skip to main content
. 2012 Sep 18;7(9):e45223. doi: 10.1371/journal.pone.0045223

Figure 4. Immunocytochemistry analysis on the expression of PEDF (a, c) and VEGF (b, d) in ECSC.

Figure 4

It shows that CSO-SA/PEDF treatment for 48 h (c) in ECSC increases the PEDF expression significantly compared to controls (a), while decreases the VEGF expression significantly compared to controls (d). (original magnification ×400).